Wendy Kao – REGiMMUNE

REGiMMUNE Appoints Dr Steve Yang as Chief Executive Officer

TAIPEI, November 4, 2025 – REGiMMUNE Limited (“REGiMMUNE” or “the [...]

Wendy Kao2025-11-04T08:01:03+00:00October 30th, 2025|

TAIPEI, October 30, 2025 – REGiMMUNE Limited (“REGiMMUNE” or “the [...]

Wendy Kao2025-10-30T07:44:25+00:00October 30th, 2025|

Taipei, 27 March 2025 – REGiMMUNE Limited, a biotech company [...]

Wendy Kao2025-03-27T10:48:01+00:00March 27th, 2025|

The intended merger will create a pan-global Treg specialist to [...]

Wendy Kao2024-10-21T06:47:01+00:00October 18th, 2024|

TAIPEI, June 4, 2024 – REGiMMUNE Limited is pleased to [...]

Wendy Kao2024-06-04T08:36:43+00:00June 4th, 2024|

TAIPEI, May 6, 2024 – REGiMMUNE Limited, a clinical-stage biopharmaceutical [...]

Wendy Kao2024-05-06T06:00:43+00:00May 6th, 2024|

TAIPEI, April 11, 2024 – REGiMMUNE Limited, a clinical-stage biopharmaceutical [...]

Wendy Kao2024-05-06T06:00:57+00:00April 15th, 2024|

TAIPEI, February 22, 2024 – REGiMMUNE Limited, a clinical-stage biopharmaceutical [...]

Wendy Kao2024-03-04T04:56:19+00:00March 1st, 2024|

TAIPEI, December 28, 2023 – REGiMMUNE Limited, a clinical-stage biopharmaceutical [...]

Wendy Kao2023-12-28T02:40:09+00:00December 27th, 2023|

Taipei, July 6, 2023 – REGiMMUNE Limited (REGiMMUNE), a biotech [...]

Wendy Kao2023-07-07T06:43:34+00:00July 7th, 2023|